Aktis Oncology AKTS
NASDAQ AKTS
$16.62 +0.34 (+2.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Aktis Oncology (AKTS) Other Operating Expenses (2025 - 2026)

Updated

Aktis Oncology (AKTS) posted Other Operating Expenses of $32.13 million for Q3 2026, up 95.1% from $16.47 million a year earlier and up 123.5% from the prior quarter.

Analysis

Aktis Oncology (AKTS) Other Operating Expenses (2025 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Other Operating Expenses at Aktis Oncology was $75.64 million; for FY2025, it came in at $67.45 million, up 64.7% from FY2024.

  • In prior years, Aktis Oncology's Other Operating Expenses was $40.95 million in FY2024.
  • On a year-over-year basis, Other Operating Expenses has increased in each of the last three quarters.
  • According to Business Quant data, Other Operating Expenses for the three prior quarters was $14.38 million (Q2 2026), $12.65 million (Q1 2026) and $16.49 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Aktis Oncology 895.95 Mn 335.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 599,000.00
Mar 31, 2026 556,000.00
Jun 30, 2025 255,000.00
Mar 31, 2025 381,000.00
API Access

Aktis Oncology Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=AKTS&period=max&api_key=YOUR_API_KEY